Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer

[1]  G. Srikrishna.  S100A8 and S100A9: New Insights into Their Roles in Malignancy , 2011, Journal of Innate Immunity.

[2]  Chaohua Li,et al.  Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. , 2011, World journal of gastroenterology.

[3]  H. Lehnert,et al.  Local calprotectin production in colorectal cancer and polyps—active neutrophil recruitment in carcinogenesis , 2011, International Journal of Colorectal Disease.

[4]  H. Kawai,et al.  Prognostic impact of S100A9 overexpression in non-small cell lung cancer , 2011, Tumor Biology.

[5]  Eithne Costello,et al.  Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. , 2010, Carcinogenesis.

[6]  Michelle L. Reyzer,et al.  Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. , 2010, Journal of proteome research.

[7]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[8]  G. Baltogiannis,et al.  Moving from Lymph Node Metastasis in Gastric Cancer to Biological Markers , 2010, World Journal of Surgery.

[9]  W. Chazin,et al.  S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. , 2009, European journal of pharmacology.

[10]  M. Hirokawa,et al.  S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma. , 2009, Anticancer research.

[11]  S. Ghavami,et al.  S100A8/A9: a mediator of severe asthma pathogenesis and morbidity? , 2009, Canadian journal of physiology and pharmacology.

[12]  D. Roukos.  Genome-wide association studies: how predictable is a person’s cancer risk? , 2009, Expert review of anticancer therapy.

[13]  D. Foell,et al.  Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage , 2009, Gut.

[14]  Seung-Yong Jeong,et al.  Evaluation of Calgranulin B in Stools from the Patients with Colorectal Cancer , 2008, Diseases of the colon and rectum.

[15]  Yasuhiro Ito,et al.  S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. , 2008, Current cancer drug targets.

[16]  J. Jones,et al.  A review of the S100 proteins in cancer. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  S. Akira,et al.  Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis , 2008, Proceedings of the National Academy of Sciences.

[18]  W. Nacken,et al.  Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock , 2007, Nature Medicine.

[19]  R. Montironi,et al.  The S100 proteins for screening and prognostic grading of bladder cancer. , 2007, Histology and histopathology.

[20]  Eithne Costello,et al.  The expression of S100A8 in pancreatic cancer‐associated monocytes is associated with the Smad4 status of pancreatic cancer cells , 2007, Proteomics.

[21]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[22]  Jack D Bui,et al.  Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? , 2007, Current opinion in immunology.

[23]  D. Foell,et al.  S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules , 2007, Journal of leukocyte biology.

[24]  C. Geczy,et al.  Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease , 2007, Scandinavian journal of gastroenterology.

[25]  P. Angel,et al.  S100A8 and S100A9 in inflammation and cancer. , 2006, Biochemical pharmacology.

[26]  T. Vogl,et al.  Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. , 2006, Journal of molecular biology.

[27]  J. Weinstein,et al.  Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.

[28]  David D. Smith,et al.  Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Grobholz,et al.  Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer , 2005, Clinical Cancer Research.

[30]  J. Roth,et al.  Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14) , 2005, Biological chemistry.

[31]  S. Cross,et al.  Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers , 2005, Histopathology.

[32]  T. Teratani,et al.  S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. , 2004, European journal of cancer.

[33]  Jun Zhao,et al.  Expression of MRP14 gene is frequently down-regulated in Chinese human esophageal cancer , 2004, Cell Research.

[34]  S. Yui,et al.  Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. , 2003, Biological & pharmaceutical bulletin.

[35]  C. Moskaluk,et al.  Gastric cancers overexpress S100A calcium-binding proteins. , 2002, Cancer research.

[36]  Rui Li,et al.  Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines , 2002, Oncogene.

[37]  D. Klimstra,et al.  Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients , 2000, Annals of surgery.

[38]  E. Vollmer,et al.  Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. , 1994, Transplantation.

[39]  T. Halstensen,et al.  Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. , 1994, Gut.

[40]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[41]  Gavin P Dunn,et al.  Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. , 2006, Advances in immunology.

[42]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[43]  D. Birnbaum,et al.  BMC Cancer , 2003 .

[44]  M. Gjomarkaj,et al.  Monocytes. , 1998, The Journal of allergy and clinical immunology.